Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

The Company was previously affiliated with PerkinElmer, Inc.

11-May-2023 - Revvity, Inc. officiallylaunched as a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere. Born from two words, “revolutionize” (rev) and “vita” (vit) meaning “life” in Latin, Revvity delivers end-to-end expertise and ...

Bayer opens first Co.Lab Life science incubator in Cambridge

Supporting cutting-edge cell and gene therapy entrepreneurs

10-May-2023 - Bayer AG announced the inauguration of its new life science incubator dubbed “Co.Lab Cambridge” located in Kendall Square in Cambridge, U.S.. Bayer’s Co.Lab Cambridge is specifically designed to support cutting-edge cell and gene therapies (CGT) entrepreneurs with access to Bayer’s enterprise ...

Magnetic bacteria can help to extract dangerous heavy metals from wastewater

Filigree sewage plants

10-May-2023 - A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has managed to purify water containing uranium using a special kind of bacteria known as magnetotactic bacteria. The name derives from their ability to react to magnetic fields. They can accumulate dissolved heavy metal in their ...

LenioBio announces new CEO

Founder will be stepping down as CEO

09-May-2023 - LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr. Remberto Martis, will be stepping down as CEO and has proudly named his successor as André Goerke, starting June 1st, 2023 André has previously held senior positions in ...

WACKER Purchases ADL BioPharma in Spain, Strengthening Its Biotechnology Business

Purchase price exceeds €100 million

09-May-2023 - The WACKER chemical group headquartered in Munich has acquired 100 percent of the shares of contract manufacturing company (CMO) ADL BioPharma. The shares were purchased from Kartesia, a financial investor with whom WACKER signed a corresponding agreement finalizing the transaction last week. ...

Artificial photosynthesis for environmentally friendly food production

Researchers produce important amino acid from greenhouse gas CO₂

03-May-2023 - Ensuring the supply of food to the constantly growing world population and protecting the environment at the same time are often conflicting objectives. Now researchers at the Technical University of Munich (TUM) have successfully developed a method for the synthetic manufacture of nutritional ...

Pall and Cytiva join forces

Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology

02-May-2023 - Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand. With nearly 16 000 associates in 40 countries, and more than 300 years' heritage of trusted expertise, the new Cytiva supports customers in solving ...

New Start-up develops aquafarms for macroalgae

AWI and Carbonwave spin-off: Large algae simultaneously bind CO₂ and create raw materials for the chemical industry

02-May-2023 - The company MACROCARBON SL has just been founded in Las Palmas, on the Canary Islands. It is a spin-off from the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) and Carbonwave. The start-up is developing algae farms, in which the macroalgae Sargassum will be ...

Sanofi completes acquisition of Provention Bio

02-May-2023 - Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per ...

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

Investment of 350 million euros is Boehringer Ingelheim's largest single investment in Germany to date

26-Apr-2023 - Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center (BDC) in Biberach an der Riß, Germany. The new high-tech facility underlines the company’s strong commitment to Germany and Europe as location for research and development (R&D) for the care of patients around ...